Fatigue

About this term

Quick definition

Persistent low energy that is not relieved by rest, beyond what would be expected from the person's activity level.

Full clinical definition

Fatigue or loss of energy nearly every day is one of the nine diagnostic criteria for a major depressive episode in the DSM-5-TR. The clinical version is more than ordinary tiredness. It is a persistent, often disproportionate, sense of low energy that does not improve with sleep and that interferes with work, school, and household function. Fatigue in depression overlaps with hypersomnia (sleeping more) and with psychomotor slowing, but it is its own symptom.

Epidemiology

Fatigue is one of the most common symptoms of a major depressive episode. Across clinic and community samples, somewhere between 70 and 90 percent of patients in an active major depressive episode report clinically significant fatigue (Ferentinos et al., Eur Psychiatry, 2011; Targum and Fava, Innov Clin Neurosci, 2011). It is also one of the most common residual symptoms after partial treatment response and is one of the leading reasons for incomplete remission in clinic populations. In primary care, fatigue is among the top three presenting complaints, which is part of why depression and medical causes of fatigue have to be considered together rather than in sequence.

What it can feel like

Heaviness in the limbs. Mental tiredness early in the day. A feeling of running on empty. The need to lie down after small tasks. Showers and meals that feel like work. In some patients, an inability to start tasks even with full awareness of what needs to be done. Some patients describe a split between physical and cognitive fatigue: the body feels heavy and slow, while the mind feels foggy, unfocused, and slow to land on a thought. Others describe a sense that even small social demands, such as a short phone call, require recovery time that would have been unimaginable before the episode began.

Why it matters

Fatigue is one of the most disabling symptoms of depression and one of the most common residual symptoms after partial treatment response. It is also common in several medical conditions, which is why a clinician usually checks both the psychiatric and the medical sides of the picture. Persistent fatigue after mood improvement is associated with higher rates of relapse, more days out of work, and a lower probability of full functional recovery, which is part of why it is worth treating in its own right rather than waiting for it to resolve passively. Fatigue is also a frequent driver of premature antidepressant discontinuation, since patients who do not feel meaningfully more energetic in the first one to two months sometimes conclude the medication is not working before a fair trial has been completed.

Differential diagnosis

Fatigue is one of the least specific symptoms in medicine, so a careful differential matters. Depression-related fatigue typically tracks with low mood, loss of interest, and other depressive symptoms, improves with mood improvement, and is not relieved by extra sleep. Iron deficiency anemia and other anemias cause fatigue that often comes with pallor, shortness of breath on exertion, and a low hemoglobin on basic labs. Hypothyroidism causes fatigue with cold intolerance, weight gain, constipation, and an elevated thyroid-stimulating hormone. Obstructive sleep apnea causes daytime fatigue with snoring, witnessed apneas, morning headache, and a higher risk in patients with elevated body mass index or large neck circumference. Chronic fatigue syndrome (myalgic encephalomyelitis) is a separate diagnosis defined by post-exertional malaise lasting more than 24 hours, unrefreshing sleep, and cognitive impairment for at least six months. Multiple sclerosis causes fatigue with neurological signs such as optic neuritis, sensory changes, or weakness, often in younger adults. Postviral fatigue, including post-COVID fatigue, can persist for months after an acute infection and may overlap with both depression and chronic fatigue syndrome.

Mechanism

Several mechanisms are thought to contribute to depression-related fatigue. Hyperactivity of the hypothalamic-pituitary-adrenal (HPA) axis, with elevated cortisol output and blunted diurnal variation, is a consistent finding in melancholic depression and is associated with poor energy. Chronic low-grade inflammation, with elevated peripheral cytokines such as interleukin-6 and C-reactive protein, has been linked to fatigue, anhedonia, and reduced motivation, both in depression and in medically ill populations. Changes in sleep architecture, including reduced slow-wave sleep and shortened REM latency, contribute to the sense that sleep is not restorative. Disturbances in monoamine signaling, particularly dopamine and norepinephrine, are implicated in the motivational and physical components of fatigue, which is part of the rationale for noradrenergic and dopaminergic agents in fatigue-predominant depression.

How clinicians assess it

Assessment usually begins with a brief clinical interview that maps out energy across the day, hours of sleep, sleep quality, snoring or witnessed apneas, daytime naps, recent infections, weight change, and the effect of fatigue on work and household function. PHQ-9 item 4 ("Feeling tired or having little energy") screens for the symptom. A focused screening lab workup typically includes thyroid-stimulating hormone, complete blood count, basic metabolic panel, and ferritin in women of reproductive age; vitamin B12, vitamin D, and HbA1c are added when the history suggests them. A sleep study is added when obstructive sleep apnea is suspected. Imaging and autoimmune workup are reserved for cases where the history or exam suggests a specific cause.

Treatment implications

Treatment of the underlying depression is the main path, and fatigue often improves with response. When fatigue is the dominant symptom, bupropion and serotonin-norepinephrine reuptake inhibitors (SNRIs) are sometimes preferred over selective serotonin reuptake inhibitors, on the rationale that noradrenergic and dopaminergic activity is more closely tied to energy and motivation. Among lifestyle interventions, exercise has the strongest evidence base for depression-related fatigue and for depression more broadly; a 2024 BMJ network meta-analysis of 218 randomized trials (Noetel et al.) found that walking, jogging, yoga, and strength training were each associated with clinically meaningful reductions in depressive symptoms, with the largest effects at moderate to vigorous intensity. The same analysis found that exercise had effect sizes comparable to standard psychotherapy and pharmacotherapy in the trials reviewed, which is a reason it is increasingly recommended as a first-line or adjunctive intervention rather than as an afterthought. Sleep regularity, treatment of any underlying sleep disorder, daytime light exposure, and a graded return to physical activity all support the change. Persistent fatigue after mood improvement is a reason to revisit medical contributors and to consider a treatment adjustment, which can include switching antidepressant class, adding bupropion or modafinil, treating an undiagnosed sleep disorder, or addressing a medical contributor identified on lab workup.

Course and prognosis

Fatigue often lags behind mood and interest in the recovery trajectory of a major depressive episode, sometimes by several weeks. Patients who reach remission on standardized scales but continue to report meaningful fatigue are at higher risk of relapse and of partial functional recovery, particularly in occupations with high cognitive or physical demand. For many patients, the most useful framing is that fatigue is a treatment target in its own right, not just a symptom that will quietly disappear once the rest of the episode resolves. Setting an explicit goal of returning energy to a workable baseline, and reassessing it at follow-up visits, is more effective than waiting for spontaneous resolution.

Practical examples

A 45-year-old woman with major depressive disorder reports profound fatigue, a flat mood, and difficulty completing routine work tasks. Initial labs (TSH, complete blood count, basic metabolic panel, ferritin, vitamin D) are unremarkable. A sleep history reveals loud snoring and witnessed apneas reported by her partner. A sleep study confirms moderate obstructive sleep apnea. Treatment with continuous positive airway pressure produces meaningful improvement in fatigue within four weeks, and her antidepressant response improves in parallel. A 30-year-old man in remission on a selective serotonin reuptake inhibitor reports that his mood is back to baseline but his energy remains noticeably reduced. After a discussion of options, his clinician switches him to an SNRI and adds a structured program of moderate-intensity aerobic exercise three times per week; his fatigue improves over the following two months and he is able to return to a full work schedule.

Related terms

Anhedonia. Psychomotor slowing. Major depressive disorder. Bupropion.

Related articles

Fatigue and depression. Sleep changes. Treatment.

Sources

• American Psychiatric Association. DSM-5-TR.
• Ferentinos P, et al. Fatigue and somatic anxiety in patients with major depressive disorder. Eur Psychiatry. 2011.
• Targum SD, Fava M. Fatigue as a residual symptom of depression. Innov Clin Neurosci. 2011.
• Noetel M, Sanders T, Gallardo-Gómez D, et al. Effect of exercise for depression: systematic review and network meta-analysis of randomised controlled trials. BMJ. 2024.